AffyImmune Therapeutics
VerifiedBiopharmaceutical company developing genetically engineered immune cells to fight cancer.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$40—60m (Dealroom.co estimates Oct 2021.)
Natick Massachusetts (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $0.0 | round | |
$10.0m | Series A | ||
| Total Funding | 000k | ||